Skip to main content
ATRC
NASDAQ Industrial Applications And Services

AtriCure Swings to Q2 Profit on 12.8% Revenue Growth; SentreHEART Lawsuit Seeks $260M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$37.31
Mkt Cap
$1.889B
52W Low
$25.36
52W High
$43.18
52W Position info
47% above low
Off High info
14% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ATRC sits 47% above its 52-week low of $25.36.

Summary

AtriCure reported Q2 2026 net income of $9.0M on revenue of $153.6M (+12.8% YoY), with gross margin improving to 77.2%. The 10-Q also reveals a lawsuit seeking up to $260M related to the SentreHEART acquisition.


Key Events · Earnings and Guidance · ATRC

  • Q2 Revenue +12.8% to $153.6M

    Worldwide revenue rose 12.8% (12.4% constant currency), driven by pain management (+27.8%), appendage management (+14.4%), and open ablation (+12.1%). U.S. revenue grew 13.6%.

  • Net Income Swings to $9.0M Profit

    Net income of $9.0M ($0.18 diluted EPS) compared to a $6.2M loss in Q2 2025, aided by a 269 bps gross margin expansion to 77.2% and a $5M reduction in R&D milestone payments.

  • Lawsuit Seeks Up to $260M in Damages

    Former SentreHEART securityholders allege breach of contract and seek damages up to $260M plus interest. The company intends to defend vigorously; no liability has been recorded as a loss is not probable or estimable.

  • Strong Liquidity Position

    Cash and equivalents of $167.8M, $62.75M unused borrowing capacity under the ABL facility, and $61M in long-term debt. Operating cash flow was $18.2M for H1 2026.


Analysis · ATRC · Industrial Applications And Services

A sharp swing to profitability highlights the quarter, with net income reaching $9.0M on revenue of $153.6M, reversing a year-ago loss. Gross margins expanded nearly 270 basis points, and the balance sheet remains solid with $167.8M in cash. However, the filing also discloses a lawsuit from former SentreHEART securityholders seeking up to $260M in damages — an amount that dwarfs the company's market cap and could become a material overhang if the case advances.

At the time of this filing, ATRC was trading at $37.31 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $25.36 to $43.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATRC - Latest Insights

ATRC
Jul 23, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.71
Real-time Price: $37.32 info
Change: +$2.61 (+8%) info
Market Cap: $1.89B info
ATRC
May 19, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.80
Real-time Price: $37.32 info
Change: +$8.52 (+30%) info
Market Cap: $1.89B info
ATRC
May 05, 2026, 9:01 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $30.40
Real-time Price: $37.32 info
Change: +$6.92 (+23%) info
Market Cap: $1.89B info
ATRC
May 05, 2026, 4:23 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $29.50
Real-time Price: $37.32 info
Change: +$7.82 (+27%) info
Market Cap: $1.89B info
ATRC
May 05, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.39
Real-time Price: $37.32 info
Change: +$7.93 (+27%) info
Market Cap: $1.89B info